Inflammation-related indicators to distinguish between gastric stromal tumors and leiomyomas: A retrospective study

doi:10.12998/wjcc.v10.i2.458

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4356)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

196

WORD

107

HTML

1725

Figures (1-2)

254

Tables (1-4)

284

Sum=2566

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

264

Download

525

Sum=789

Publishing Process of This Article

Item

Count

Browse

327

Download

674

Sum=1001

Jan 14, 2022 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Jan 14, 2022; 10(2): 458-468
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.458

Table 1 Baseline characteristics of patients in gastrointestinal stromal tumors group and gastric leiomyoma group

Characteristics	GIST group (n = 88), (%)		Gastric leiomyoma group (n = 56), (%)		P value
Gender (male/female)	47/41	53.4/46.6	18/38	32.1/67.9	0.012^a
Age (median)	61.1		50.1		0.00^a
ECOG					0.31
0	86	97.7	52	92.8
1	1	1.1	3	5.3
2	1	1.1	1	1.7
Tumor location					0.00^a
Cardia	3	3.4	25	44.6
Fundus	46	52.2	20	35.7
Body	27	30.7	8	14.3
Antrum	12	13.6	3	5.3
Diameter					0.122
≤ 2 cm	11	12.5	14	25
2-5 cm	54	61.4	32	57.1
≥ 5 cm	23	26.1	10	17.9

^aP < 0.05.

GIST: Gastrointestinal stromal tumors; ECOG: Eastern Cooperative Oncology Group.

Table 2 Inflammation indicators of the two groups

	GIST (n = 88)	Gastric leiomyoma (n = 56)	t value	P value
PLR	158.2 ± 8.7	134.3 ± 6.2	2.217	0.028^a
NLR	2.35 ± 0.17	1.68 ± 0.08	3.617	0.00^a
LMR	5.76 ± 0.56	10.82 ± 1.62	2.956	0.004^a
SII	546.2 ± 49.3	384.3 ± 22.1	2.993	0.003^a

^aP < 0.05.

GIST: Gastrointestinal stromal tumors; PLR: Platelet-lymphocyte ratio; NLR: Neutrophil-lymphocyte ratio; LMR: lLymphocyte mononuclear cell ratio.

Table 3 Logistic regression analysis results

	Group	β	SE	Wald	P value	OR	95%CI
Gender	Male	-	-	-	-	1	-
Gender	Female	1.548	0.548	7.97	0.005	4.7	1.605-13.762
Age		-0.097	0.024	16.939	0	0.907	0.866-0.950
Tumor locations	Cardia	-	-	-	-	1	-
	Fundus	-3.501	0.804	18.948	0	0.03	0.006-0.146
	Body	-3.572	0.854	17.482	0.001	0.028	0.005-0.150
	Antrum	-3.315	1.039	10.19	0.001	0.036	0.005-0.278
LMR		0.092	0.042	4.715	0.03	1.096	1.009-1.191

LMR: lLymphocyte mononuclear cell ratio.

Table 4 Subgroup analysis of low-risk gastrointestinal stromal tumors and gastric leiomyoma

	Low-risk GIST (n = 56)	Gastric leiomyoma (n = 56)	t value	P value
PLR	146.1 ± 9.9	134.3 ± 6.2	0.992	0.324
NLR	2.17 ± 0.17	1.68 ± 0.08	2.451	0.016^a
LMR	5.42 ± 0.32	10.82 ± 1.62	3.267	0.002^a
SII	484.5 ± 56.1	384.3 ± 22.1	1.661	0.101

^aP < 0.05.

GIST: Gastrointestinal stromal tumors; PLR: Platelet-lymphocyte ratio; NLR: Neutrophil-lymphocyte ratio; LMR: lLymphocyte mononuclear cell ratio.

Citation: Zhai YH, Zheng Z, Deng W, Yin J, Bai ZG, Liu XY, Zhang J, Zhang ZT. Inflammation-related indicators to distinguish between gastric stromal tumors and leiomyomas: A retrospective study. World J Clin Cases 2022; 10(2): 458-468
URL: https://www.wjgnet.com/2307-8960/full/v10/i2/458.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.458